(Q47974624)

7 February 2018

reason for preferred rank

title

Lowering of plasma concentrations of (+)-6-methoxy-α-methyl-2-naphthaleneacetic acid (naproxen) by aspirin in rats (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

26 February 2023

Lowering of plasma concentrations of (+)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid (naproxen) by aspirin in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4729806

26 February 2023

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

26 February 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

26 February 2023

author name string

M. D. Chaplin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4729806

26 February 2023

language of work or name

English

0 references

publication date

1 July 1973

1 reference

7 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0006295273900257?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

https://api.elsevier.com/content/article/PII:0006295273900257?httpAccept=text/plain

26 February 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

26 February 2023

published in

Biochemical Pharmacology

1 reference

7 February 2018

volume

22

1 reference

7 February 2018

issue

13

1 reference

7 February 2018

page(s)

1589-1598

1 reference

7 February 2018

Absorption, Distribution, Metabolism, and Excretion of Naproxen in Various Laboratory Animals and Human Subjects

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

Interaction of aspirin with nonsteroidal anti-inflammatory drugs in rats

26 February 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

Comparative effects of salicylic acid, phenylbutazone, probenecid and other anions on the metabolism, distribution and excretion of indomethacin by rats

26 February 2023

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

Protein measurement with the Folin phenol reagent

26 February 2023

13

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

26 February 2023

15

12

244

Chaplin

1970

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

26 February 2023

16

12

202

Van Arman

1970

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

26 February 2023

17

12

202

Duggan

1970

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

A three-month trial of indomethacin in rheumatoid arthritis, with special reference to analysis and inference

26 February 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

The effect of aspirin on serum indomethacin

26 February 2023

20

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids

26 February 2023

22

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

Potentiation of anticoagulant effect of warfarin by phenylbutazone

26 February 2023

23

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

Potentiation of Warfarin-Induced Hypoprothrombinemia by Chloral Hydrate

26 February 2023

24

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

Mechanism of action of neostigmine at the neuromuscular junction

26 February 2023

25

1 reference

https://api.crossref.org/works/10.1016/0006-2952(73)90025-7

26 February 2023

Identifiers

1 reference

7 February 2018

1 reference

7 February 2018